Mallinckrodt is a manufacturer of opioid pain medication that filed for chapter 11 bankruptcy in October 2020. On June 17, 2021, Mallinckrodt plc and its affiliates (the “Debtors”) filed their Plan of Reorganization (the “Plan”) and a related Disclosure Statement in the United States Bankruptcy Court for the District of Delaware.
This website provides information about the Debtors’ proposed Plan, including how individuals and corporate entities harmed by the Debtors’ opioid products can cast a vote on the Plan. Copies of the Plan and related documents, including the Disclosure Statement and a letter from the Official Committee of Opioid Related Claimants (a representative of opioid claimants in the Debtors’ bankruptcy cases appointed by the Office of the United States Trustee) setting forth its position regarding the Plan can be obtained free of charge by clicking the applicable Quick Link on the left side of this page.
WHAT DOES THE PLAN PROVIDE FOR OPIOID CLAIMANTS?
Mallinckrodt’s Plan channels claims based on harm or injury related to the Debtors’ opioid products to one or more opioid trusts. These opioid trusts will be established to distrubute money to individuals and corporate entities holding Opioid Claims and to abate the opioid crisis. If the Plan is approved by the Bankruptcy Court and you have an Opioid Claim, you will be entitled to assert your claim directly against the applicable opioid trust at a later time.
There is nothing you need to do right now to assert your Opioid Claim. Information regarding how to assert your Opioid Claim against an opioid trust will be made available at a later date.
Because the Plan proposes to channel all Opioid Claims to the opioid trusts for payment, the Plan, if approved, will forever prohibit all opioid claimants from asserting any Opioid Claim against or seeking any money on account of any Opioid Claim from the Debtors, their officers and directors and certain other parties specified in the Plan as “Protected Parties” regardless of whether such claimants vote on the Plan or assert claims against an opioid trust at a later date.
WHO CAN VOTE ON THE PLAN?
If you think you or a deceased loved one has been harmed by an opioid product such as Hydrocodone, Oxycodone, Codeine or Roxicodone, or if you care for a child who was exposed to these opioids in the womb, you can vote on Mallinckrodt’s Plan.
HOW DO I VOTE?
You may vote through the following two options:
OPTION 1 (IF YOU DO NOT HAVE A BALLOT ID)
If you do NOT have a Ballot ID, Submit a Ballot Online Here: Click here to submit a Ballot online to cast your vote on the Plan. After you submit your Ballot, you will receive an email with a confirmation number, which you must retain in the event you are asked to verify your vote or you wish to amend your Ballot.
Amending a Ballot: If you already submitted a Ballot using Option 1 and want to amend your previously submitted Ballot, please click the link in Option 1 above, enter your confirmation number, follow the instructions, and submit a new Ballot online.
Amending a Ballot using your Ballot ID: If you already submitted a Ballot using Option 2 and want to amend your previously submitted Ballot, please click the link in Option 2 above, enter your Ballot ID number, follow the instructions, and submit a new Ballot online.
OPTION 2 (IF YOU HAVE A BALLOT ID)
If you have a Ballot ID, Submit a Ballot Online Here: If you have already obtained a pre-populated Ballot or Ballot ID, you may cast your vote by clicking here
Please note that if you are represented by an attorney, they may already have voted on your behalf if you authorized them to do so. Please be sure to check with your attorney before submitting a Ballot as noted above.
Unless you received a letter stating your deadline to submit a ballot is a different date, your Ballot must be submitted so it is received on or before October 20, 2021 at 4:00 p.m. Eastern Time.. If your Ballot is not actually received by that time, your vote will not be counted.
PLAN OBJECTION DEADLINE
The deadline to file an objection to the Plan is October 20, 2021 at 4:00 p.m. Eastern Time. There are requirements that must be followed to file an objection, which are set forth in the Disclosure Statement Order, which is available here. Objections received after the deadline may not be considered by the Bankruptcy Court and may be deemed overruled without further notice.
THE OFFICIAL COMMITTEE OF OPIOID RELATED CLAIMANTS
The United States Trustee appointed seven creditors to serve on the Official Committee of Opioid Related Claimants (the “OCC”) and represent the interests of all of the Debtors’ opioid-related creditors . The OCC has prepared a letter setting forth its position regarding the Plan, which is available here. Opioid claimants may direct any inquiries regarding the Debtors’ bankruptcy cases to either (i) MallinckrodtOpioidClaimantInfo@akingump.com or (ii) MLNKOpioidcreditorinfo@primeclerk.com. You may also reach the OCC Hotline at either 877.720.6579 (Toll-Free) or +1 347.532.7902 (International). The OCC maintains an informational website available here.
DEBTORS’ CASE WEBSITE
The Debtors maintain an informational website available here containing all items filed with the Bankruptcy Court in these proceedings a calendar of important dates and other information.